3D Tissue Models
Second Health Technology Assessment (HTA) Conference
Radisson Blu Hotel Paris Charles De Gaulle Airport

mm, United Kingdom
 The Health Technology Assessment ( HTA ) landscape in Europe is
   currently under the spotlight more than ever before. It is changing,
   evolving and is in an increasingly dynamic state of flux, as agencies
   here and globally try to figure out the right pathway forward to
   ensure that the right treatments are made available to patients in
   sustainable healthcare frameworks.

   HTA is also increasingly, therefore, becoming the focus of the
   stakeholders involved all stages of the medicines development process.
   Patients are proactively engaging with evaluators and payers.
   Innovative medicines manufacturers are working to build understanding
   of the value of their products

Schedule of Presentations:

Thursday, November 4, 2010
08:00:00 Registration
09:00:00 The "Benefit/Risk" Management Plan - How would you generate one in practice? Angelika Joos
09:05:00 European Medicines Agency Vision for "Benefit/Risk" Management Plans Hans-Georg Eichler
09:30:00 HTA Body perspective Francois Meyer
10:00:00 German Regulator perspective Karl Broich
10:30:00 Break
11:00:00 Panel Discussion: Building a new system to get effective orphan treatments to EU Patients - Where do we go from here? Yann Le Cam
11:30:00 PANEL DISCUSSION Giulia Del Brenna, Wills Hughes-Wilson
13:00:00 Lunch
14:00:00 Mapping the EU HTA Landscape - Where do we stand? Alicia Granados
14:10:00 HTA Landscape and Knowledge-mapping Laura Sampietro-Colom
14:30:00 The EUnetHTA Joint Action and future perspectives of HTA in Europe Jérôme Boehm
15:30:00 Break
16:00:00 Innovative Patient Access Schemes - State of the Art Giulia Del Brenna
16:30:00 Innovative Access Schemes – What is working well? Michael Ruhl
17:00:00 Industry Experiences – What is good, bad and what is really needed? Jan Oltvoort
Friday, November 5, 2010
09:00:00 Innovative Patient Access Schemes - How do we implement in practice? Kevin Loth
09:30:00 UK Experiences Eric Low
10:00:00 German Experiences Claudia Palme
10:15:00 Italian Experience Luca De Nigro
10:30:00 Break
11:00:00 What are the right methodologies to generate the right data? Clare McGrath
11:30:00 The Ground-rules and Infrastructure – What needs to be there in order to set this up? Nils Feltelius
12:00:00 How to Set-up and Use Data from Registries – The Nordic registries example Nils Feltelius
12:30:00 The Role of Observational Studies Judith Kempf
13:00:00 Patient Reported Outcomes (PROs) in a Real-life Setting
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.